Perlman syndrome is a rare genetic condition that causes overgrowth before and after birth and increases the risk of kidney tumors. Features often include large birth size, low muscle tone, feeding difficulties, breathing problems, and distinctive facial differences. Many children with Perlman syndrome have developmental delays, and doctors watch closely for early symptoms of Perlman syndrome such as rapid growth and kidney changes. It is present from birth and can be life‑limiting in severe cases, especially in infancy, but outcomes vary. Treatment focuses on supportive care, nutrition and breathing support, early therapies, and regular screening and surgery if kidney tumors develop.
Overview
Perlman syndromeSymptoms
Perlman syndrome features often appear before birth or at delivery: fast growth, large body and head, weak muscle tone, breathing trouble, and enlarged kidneys. Babies may have feeding difficulties, distinctive facial traits, and higher risk of childhood kidney tumors.
Outlook and prognosis
Many living with Perlman syndrome face serious health challenges early in life, including breathing problems, low muscle tone, and organ complications. Close monitoring in neonatal and pediatric intensive care, plus early therapies, can support growth, comfort, and development. Long‑term outlook varies widely and depends on complications.
Causes and risk factors
Perlman syndrome results from changes in the DIS3L2 gene and is inherited in an autosomal recessive pattern. Risk is higher when both parents are carriers, in consanguineous families, or with a previously affected child. Environmental or lifestyle causes aren’t known.
Genetic influences
Genetics is central in Perlman syndrome; it’s an inherited condition caused by pathogenic changes in the DIS3L2 gene. Most cases follow an autosomal recessive pattern, so parents are usually carriers. Genetic testing confirms diagnosis and guides family planning and recurrence risk.
Diagnosis
Doctors suspect Perlman syndrome from prenatal or newborn signs like overgrowth, large kidneys, and distinctive facial features. Genetic diagnosis of Perlman syndrome uses DIS3L2 testing, with imaging and lab results to support the findings.
Treatment and drugs
Treatment for Perlman syndrome focuses on supportive, team-based care tailored to each child’s needs. This can include breathing support, careful feeding and growth monitoring, managing low muscle tone, and early therapies to aid movement and development. Regular kidney and tumor screening guides timely interventions and surgery when needed.
Symptoms
Families often notice their newborn is larger than expected and needs extra support with feeding, breathing, or keeping blood sugar steady. Features vary from person to person and can change over time. Perlman syndrome is a rare genetic overgrowth condition that mainly affects the kidneys, muscle tone, and development. Care teams focus on spotting issues early so babies get timely monitoring and support.
Babies may be larger than average before birth and at delivery. Parents and doctors may notice early features of Perlman syndrome such as a big birth size and a broad, soft body build.
During pregnancy, scans may show extra amniotic fluid and a larger baby. Some families hear about possible kidney enlargement or other organ growth on ultrasound.
Kidneys can be bigger than usual, sometimes with areas of immature tissue that need close follow-up. In Perlman syndrome, this can raise the chance of kidney problems in infancy.
Children with Perlman syndrome have a higher risk of Wilms tumor (a childhood kidney cancer). Doctors usually recommend regular kidney ultrasounds to catch changes early.
How people usually first notice Perlman syndrome?
Many families first notice signs of Perlman syndrome before birth, when routine ultrasound shows a very large baby for gestational age (prenatal overgrowth), too much amniotic fluid (polyhydramnios), and sometimes enlarged kidneys. At birth, doctors often recognize the first signs of Perlman syndrome through pronounced overgrowth, low muscle tone, breathing difficulties, distinctive facial features, and kidney enlargement that can lead to low blood sugar and other early complications. In the first days to weeks, close monitoring may reveal feeding challenges, developmental delays, or kidney-related issues, which together help confirm how Perlman syndrome is first noticed.
Types of Perlman syndrome
Perlman syndrome is a rare genetic condition present from birth, and doctors recognize that severity can vary. Most descriptions point to one clinical picture driven by changes in the DIS3L2 gene, rather than clearly separated subtypes. Because there are no widely accepted variants, discussions of types of Perlman syndrome usually focus on how early features show up and how strong they are. Not everyone will experience every type.
No distinct variants
At this time, experts do not agree on separate clinical variants of Perlman syndrome. Most people have changes in the same gene, with differences mainly in symptom severity rather than true subtypes.
What genetics can tell you about symptoms
Some babies with Perlman syndrome have low muscle tone, breathing troubles, feeding difficulty, and very fast growth before and after birth, linked to DIS3L2 gene changes that disrupt cell growth control. These changes also raise risks for kidney enlargement and Wilms tumor.
Causes and risk factors
The main cause of Perlman syndrome is a change in a gene called DIS3L2.
It is usually inherited when both parents carry one nonworking copy, so each pregnancy has a 25% chance of being affected.
Rarely, a new gene change can cause Perlman syndrome even without a known family history.
Related parents have a higher chance of both being carriers, but lifestyle or diet do not cause this condition.
Not everyone with the same risk develops the condition.
Environmental and biological risk factors
Perlman syndrome is present from birth, so prevention focuses less on avoidable exposures and more on careful prenatal recognition. Researchers are still exploring how outside influences interact with our inner biology. Families may hear about early symptoms of Perlman syndrome during routine ultrasound reviews; these are signs that help doctors monitor the pregnancy, not causes of the condition. Below we summarize what is known about environmental and biological risks.
Older maternal age raises the chance of some chromosomal conditions, but it hasn’t been shown to increase risk for Perlman syndrome. Younger maternal age also has not been linked to higher likelihood.
Advanced paternal age has been tied to a few conditions, but increased risk here has not been demonstrated. No specific paternal age range has been associated.
Health issues such as diabetes or high blood pressure can affect pregnancy course, but they have not been shown to cause this syndrome. Good prenatal care supports overall fetal well-being even though it doesn’t change the underlying likelihood.
High-dose radiation or toxic metals can harm fetal development, yet no specific exposure has been proven to trigger Perlman syndrome. Following routine safety guidance in pregnancy remains sensible while research continues.
Genetic risk factors
Most cases trace back to changes in a single gene that helps control cell growth. Some risk factors are inherited through our genes. The genetic causes of Perlman syndrome usually involve two changes in the DIS3L2 gene, one from each parent. A small number of families have similar features without a confirmed DIS3L2 change, suggesting other rare genes may be involved.
DIS3L2 variants: Changes in the DIS3L2 gene are found in most people with Perlman syndrome. These changes disrupt normal growth control and organ development. Genetic testing can look for these variants.
Recessive inheritance: Perlman syndrome follows an autosomal recessive pattern. If both parents are carriers, each pregnancy has a 25% (1 in 4) chance of a child with the condition. Carriers usually have no symptoms.
Family history: Having a sibling or prior child with Perlman syndrome raises the chance in future pregnancies. When the family’s DIS3L2 variants are known, targeted testing can clarify risk. Genetic counseling can explain recurrence numbers.
Parental relatedness: When parents are related by blood, they are more likely to carry the same rare DIS3L2 change. This increases the chance that a child inherits two changes. The overall risk still depends on whether both parents are carriers.
Other rare genes: A small number of families meet clinical criteria but test negative for DIS3L2 changes. In these cases, the genetic cause is not yet known. Research is underway to identify additional genes.
Lifestyle risk factors
Perlman syndrome is a genetic condition; lifestyle habits do not cause it, but they can influence symptoms, day-to-day function, and complications. This overview focuses on how lifestyle affects Perlman syndrome and clarifies that lifestyle risk factors for Perlman syndrome relate to management, not causation. Choices around feeding, activity, sleep, and safety can meaningfully support kidney health, breathing, and development.
A calorie-appropriate, nutrient-dense diet can limit excessive weight gain that worsens breathing mechanics and strains enlarged kidneys. Dietitian-guided plans support growth while avoiding unnecessary overgrowth.
For infants with hypotonia or reflux, paced feeds, thickened liquids, and upright positioning can lower aspiration risk. Smaller, more frequent meals may reduce vomiting and discomfort.
Consistent hydration supports kidney filtration when kidneys are enlarged or vulnerable. Moderating sodium under clinician guidance may help reduce blood pressure load on the kidneys.
Daily low-impact movement and PT can improve muscle tone, motor milestones, and breathing efficiency in Perlman syndrome. Avoid high-contact sports that increase the risk of abdominal trauma to enlarged kidneys.
Risk prevention
You can’t prevent the gene change that causes Perlman syndrome, but you can plan ahead and lower the chance of serious complications. Prevention works best when combined with regular check-ups. Planning can reduce risks in pregnancy and the newborn period, and ongoing monitoring can catch issues early, especially kidney problems and tumors. The steps below focus on practical ways to reduce risk and support long-term health.
A genetics visit can explain how Perlman syndrome happens and your chance of having another child with it. Counselors can walk through testing options for you and family members.
If a DIS3L2 change is found in your family, carrier testing can identify who else may pass it on. This helps with future pregnancy planning and early care.
If the family variant is known, in‑vitro fertilization with embryo testing (PGT‑M) can lower the chance of an affected pregnancy. Prenatal testing by CVS or amniocentesis can confirm whether a pregnancy has Perlman syndrome.
Extra ultrasounds can track rapid growth, kidney size, and amniotic fluid. This helps time delivery and plan the right level of newborn support.
Transmission
Perlman syndrome is not contagious—you can’t catch it or spread it through everyday contact. The genetic transmission of Perlman syndrome is usually autosomal recessive, meaning both parents typically carry one silent, nonworking copy of the DIS3L2 gene without having symptoms themselves. When two carriers have a child, each pregnancy has a 25% (1 in 4) chance of the child having Perlman syndrome, a 50% (1 in 2) chance the child will be a carrier like the parents, and a 25% chance of inheriting no changed copies. How Perlman syndrome is inherited may rarely involve a new (de novo) gene change in the egg or sperm, but this is uncommon. If Perlman syndrome runs in your family, carrier testing and genetic counseling can help clarify risks for future pregnancies.
When to test your genes
Perlman syndrome is rare and often diagnosed in infancy, but genetic testing is important if there’s a strong family history, unexplained prenatal overgrowth, kidney enlargement, or early-life tumors. Test sooner if a sibling was affected or if ultrasound flags suggestive features. Results can guide surveillance plans and family planning.
Diagnosis
Clues often show up before or shortly after birth, such as rapid growth, low muscle tone, and unusually large kidneys. Doctors look for these recognizable features and then use specific tests to confirm the cause; together, this supports a genetic diagnosis of Perlman syndrome. Early and accurate diagnosis can help you plan ahead with confidence.
Sonographers may see fetal overgrowth, extra fluid around the baby, or noticeably enlarged kidneys. These patterns raise suspicion and prompt closer monitoring and genetic testing.
Clinicians assess birth size, muscle tone, breathing, and kidney size in the first days of life. A combination of rapid growth and kidney enlargement helps distinguish Perlman syndrome from other overgrowth conditions.
A postnatal kidney ultrasound checks size and structure and looks for early signs of swelling or scarring. Imaging findings support the diagnosis of Perlman syndrome and provide a baseline for follow-up.
A blood or saliva test looks for changes in the DIS3L2 gene, which are known to cause Perlman syndrome. Confirming a DIS3L2 variant makes the diagnosis clear and can guide family counseling.
Stages of Perlman syndrome
Perlman syndrome does not have defined progression stages. It is a rare genetic condition present from birth, so features tend to appear early and the course can vary from child to child; early symptoms of Perlman syndrome may include rapid growth, low muscle tone, breathing or feeding difficulties, and kidney differences. Doctors usually diagnose it based on physical features and growth, kidney imaging such as ultrasound, and a blood test to look for changes in a gene called DIS3L2. Genetic testing may be offered to clarify certain risks.
Outlook and prognosis
Looking ahead can feel daunting, but many families focus on the next needed step and the support team around them. Perlman syndrome is a rare, severe genetic condition linked with very rapid growth before birth, kidney overgrowth, low muscle tone, feeding difficulties, and a high risk of breathing problems soon after delivery. Early symptoms of Perlman syndrome often appear in the newborn period, and the first days to weeks can be critical. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, but here the genetic drivers tend to dominate because complications start so early.
The outlook is not the same for everyone, but survival in the first year is challenging due to respiratory failure, kidney complications, and infections. If a child with Perlman syndrome survives infancy, ongoing issues can include chronic kidney disease, differences in development, seizures, feeding and growth challenges, and an increased risk of childhood kidney cancer (Wilms tumor). Regular kidney imaging and careful monitoring for tumors can improve early detection, and some children receive preventive surgery or prompt treatment if a mass appears. With ongoing care, many people maintain better comfort and fewer complications when care is coordinated across neonatology, nephrology, oncology, neurology, nutrition, and physical therapy.
Genetic testing can sometimes provide more insight into prognosis, including confirming the specific gene change and helping guide screening strategies for the kidneys. Families often want to know what role they can play.. Keeping up with scheduled scans, vaccines, respiratory care, and nutrition plans can help reduce hospitalizations and catch problems early. Talk with your doctor about what your personal outlook might look like. Understanding the prognosis can guide planning and help you prepare practical supports at home, from feeding tools to early-intervention services.
Long-term effects
Perlman syndrome is a rare genetic condition linked with overgrowth, kidney differences, and developmental challenges that begin early in life. Many newborns face serious medical needs, and survival into childhood varies by the severity of early complications. Long-term effects vary widely, and can involve learning, movement, kidney health, and a higher risk of certain childhood cancers. Articles about early symptoms of Perlman syndrome often focus on the newborn period, but the outlook centers on which features persist and how they change over time.
The highest risk of death occurs in the neonatal period due to breathing problems, infections, and organ complications. Children who live beyond infancy with Perlman syndrome often have a more stable course into later childhood.
Enlarged or structurally different kidneys can lead to chronic kidney disease over time. Some children develop high blood pressure tied to these kidney changes.
There is a high risk of Wilms tumor (a kidney cancer), especially in early childhood. In Perlman syndrome, this risk drops as children get older.
Many survivors have intellectual disability and developmental delays. Low muscle tone and coordination challenges can affect walking, speech, and daily skills.
How is it to live with Perlman syndrome?
Living with Perlman syndrome usually means navigating complex medical needs from infancy, with frequent appointments for breathing support, feeding, blood sugar monitoring, kidney and abdominal ultrasounds, and early therapies to support movement and development. Daily life often centers on managing low muscle tone, developmental delays, and a higher risk of Wilms tumor, so families get used to scheduled screenings and close coordination with pediatric, genetics, and oncology teams. Caregivers and siblings may feel stretched by hospital visits and caregiving routines, but many find a steady rhythm with home health support, respite care, and community resources, celebrating small milestones along the way.
Treatment and drugs
Perlman syndrome is treated with supportive care focused on the child’s needs, since there’s no single medicine that corrects the condition itself. Care often starts at birth with help for breathing and feeding, careful monitoring of blood sugar, and treatment of kidney problems or abnormal fluid buildup; surgery may be needed for certain structural issues or tumors. Regular screening for Wilms tumor (a childhood kidney cancer) is important, typically with frequent abdominal ultrasounds and urine or blood checks as advised by a pediatric specialist. Therapies such as physical, occupational, and speech therapy can support development, while nutrition support helps with growth and energy. Treatment plans often combine several approaches, guided by a coordinated team that may include neonatology, nephrology, oncology, genetics, and rehabilitation.
Non-drug treatment
Many babies with Perlman syndrome need hands-on support from day one, focusing on breathing, feeding, movement, and monitoring the kidneys. Early symptoms of Perlman syndrome can include weak muscle tone, trouble feeding, and breathing pauses, so care centers on comfort and safety while development grows. Non-drug treatments often lay the foundation for health and learning, with therapies and regular checks that adjust as your child grows. Teams usually include therapists, dietitians, kidney and tumor specialists, and genetics services to guide planning over time.
A referral to state or regional early‑childhood services links families with therapists soon after diagnosis. Starting services early can help skills build steadily over time.
A speech or occupational therapist can assess sucking, swallowing, and coordination. Techniques like paced feeding, nipple changes, or thickened liquids can make feeding safer and calmer.
A dietitian can tailor calories, protein, and fluids to growth and kidney health. If weight gain lags or feeding is exhausting, temporary tube feeding can provide steady nutrition.
Positioning, airway clearance techniques, and supplemental oxygen can ease breathing. Some babies benefit from noninvasive ventilation during sleep to reduce pauses and fatigue.
Your genes may have an impact on how drugs work for you
Medicines used in Perlman syndrome can behave differently because genes that process drugs—like those guiding liver enzymes—vary from person to person. Pharmacogenetic testing may help tailor doses, reduce side effects, and choose safer options when seizures, infections, or pain require treatment.
Pharmacological treatments
Drug therapy focuses on treating complications, since there’s no medicine that changes the underlying genetic cause. In Perlman syndrome, medicines may be used for kidney-related blood pressure issues, reflux, infections, seizures if they occur, and for Wilms tumor if it develops. Early symptoms of Perlman syndrome are managed supportively, often in neonatal units. Not everyone responds to the same medication in the same way.
If a Wilms tumor develops, standard pediatric cancer regimens are used. Common drugs include vincristine, dactinomycin, and doxorubicin.
If seizures occur, doctors often start levetiracetam or phenobarbital in infants. Other options like valproate may be considered later with careful monitoring.
Kidney changes can raise blood pressure, and ACE inhibitors such as enalapril or ARBs like losartan may help protect the kidneys. Amlodipine (a calcium channel blocker) is another option if needed.
When fluid builds up or kidneys are under strain, diuretics like furosemide can reduce swelling and ease breathing. Spironolactone may be added to balance potassium and control fluid over time.
Genetic influences
In most families, Perlman syndrome happens when a child inherits two nonworking copies of the same gene, called DIS3L2—one from each parent. Parents usually feel healthy because one working copy is enough for them. When both parents carry this silent change, each pregnancy has a 25% (1 in 4) chance of an affected child, a 50% (1 in 2) chance of a child who is a carrier, and a 25% chance of neither. A “carrier” means you hold the gene change but may not show symptoms. Genetic testing can look for DIS3L2 changes to help confirm the diagnosis and clarify risks for future pregnancies, though a small number of people with clear features of Perlman syndrome do not yet have an identifiable gene change. Genetic counseling can explain what the results mean for your family and discuss options such as prenatal or preimplantation testing.
Is Perlman syndrome genetic?
Genetics is central in Perlman syndrome; it’s an inherited condition caused by pathogenic changes in the DIS3L2 gene. Most cases follow an autosomal recessive pattern, so parents are usually carriers. Genetic testing confirms diagnosis and guides family planning and recurrence risk.
Pharmacogenetics—how genetics influence drug effects
In Perlman syndrome, the gene changes that cause the condition do not yet point to specific, tailored drug choices, but they do shape care by flagging higher risks to the kidneys and a possible childhood kidney tumor. Genetic testing can sometimes identify how your body processes certain medicines, so your team may consider it if chemotherapy or specific pain medicines are planned. If Wilms tumor treatment is needed, doctors typically use standard pediatric protocols; doses are adjusted mostly for age, size, and kidney function, rather than for the underlying gene change itself. Because many people with Perlman syndrome have kidney differences, drugs that can strain the kidneys—some antibiotics, contrast dyes, and certain chemotherapy agents—are chosen and dosed carefully. For anesthesia and pain control, teams avoid codeine in children and consider individual factors that affect drug breakdown to reduce the chance of over-sedation or poor pain relief. If a kidney transplant is ever needed, separate pharmacogenetic testing may help guide dosing of anti-rejection medicines at some centers. In short, how genetics influence treatment for Perlman syndrome is evolving, and care plans blend genetic information with clinical monitoring to keep therapies both safe and effective.
Interactions with other conditions
In Perlman syndrome, the most important interactions are with kidney conditions and a higher chance of childhood kidney cancer known as Wilms tumor. Because early symptoms of Perlman syndrome often include very large kidneys and rapid growth, doctors typically recommend frequent kidney checks and ultrasound screening in infancy and early childhood. Doctors call it a “comorbidity” when two conditions occur together, and in this syndrome, kidney enlargement and structural differences can also go along with high blood pressure or urinary tract infections, which may change treatment plans. Low muscle tone and feeding or breathing difficulties can make respiratory infections tougher to recover from, and they may increase anesthesia risks if a child needs surgery for kidney or abdominal issues. Features can overlap with other overgrowth conditions such as Beckwith‑Wiedemann syndrome, so teams sometimes adapt similar tumor-surveillance schedules even while tailoring care to the specific genetic cause. Close coordination among pediatrics, nephrology, oncology, and genetics helps manage how Perlman syndrome interacts with cancer risk and other health problems over time.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns who were unusually large at birth, with breathing difficulties and fragile health in the first days of life. Families and communities once noticed patterns—an older cousin who was very big as a baby, a sibling who needed intensive care—yet the reasons stayed unclear. Doctors wrote case notes about rapid growth before birth, distinctive facial features, and kidney problems, but the stories often stood alone, without a unifying explanation.
First described in the medical literature as a cluster of “overgrowth” findings in the late 20th century, Perlman syndrome gradually took shape as physicians compared rare cases from different hospitals. Early reports focused on what could be seen and measured: high birth weight, low muscle tone, and a higher chance of complications in the newborn period. Over time, descriptions became more consistent, linking these early-life patterns with later risks, such as certain kidney tumors in childhood.
In recent decades, knowledge has built on a long tradition of observation. Advances in genetics helped connect the dots, showing that changes in a gene involved in growth control underlie many cases of Perlman syndrome. This shifted the picture from a collection of puzzling signs to a recognizable condition with a shared cause for many families. Genetic testing also clarified that not all overgrowth conditions are the same, helping doctors distinguish Perlman syndrome from better-known conditions with overlapping features.
Understanding of Perlman syndrome has continued to evolve as more case series and family histories have been published. Researchers and clinicians now recognize that signs can vary from child to child. Some babies have striking prenatal overgrowth and kidney differences, while others show a milder pattern. This variability explains why older reports sometimes grouped different conditions together and why careful evaluation is so important today.
Looking back helps explain current care. What began as scattered observations about big babies and early breathing troubles now guides practical steps: careful newborn monitoring, kidney imaging, and thoughtful cancer screening in early childhood. As medical science evolved, families affected by Perlman syndrome moved from uncertainty to clearer answers, better coordinated care, and more informed counseling about future pregnancies.